Bordet R - Search Results

1

Sex Differences in Cognitive Impairment Induced by Cerebral Microhemorrhage.

Barus R, Bergeron S, Auger F, Laloux C, Skrobala E, Bongiovanni A, Potey C, Bordet R, Chen Y, Gautier S. Barus R, et al. Among authors: bordet r. Transl Stroke Res. 2021 Apr;12(2):316-330. doi: 10.1007/s12975-020-00820-1. Epub 2020 May 21. Transl Stroke Res. 2021. PMID: 32440818

2

[Concern of pharmacovigilance: proarrhythmic effects of medications in current use].

Caron J, Gautier S, Couderc E, Bordet R. Caron J, et al. Among authors: bordet r. Arch Pediatr. 1999;6 Suppl 2:231s-232s. doi: 10.1016/s0929-693x(99)80422-9. Arch Pediatr. 1999. PMID: 10370490 French. No abstract available.

3

Analysis of the direct cost of adverse drug reactions in hospitalised patients.

Bordet R, Gautier S, Le Louet H, Dupuis B, Caron J. Bordet R, et al. Eur J Clin Pharmacol. 2001 Mar;56(12):935-41. doi: 10.1007/s002280000260. Eur J Clin Pharmacol. 2001. PMID: 11317484

4

The cost of adverse drug reactions.

Gautier S, Bachelet H, Bordet R, Caron J. Gautier S, et al. Among authors: bordet r. Expert Opin Pharmacother. 2003 Mar;4(3):319-26. doi: 10.1517/14656566.4.3.319. Expert Opin Pharmacother. 2003. PMID: 12614184 Review.

5

Involvement of thrombolysis in recombinant tissue plasminogen activator-induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial function.

Gautier S, Petrault O, Gele P, Laprais M, Bastide M, Bauters A, Deplanque D, Jude B, Caron J, Bordet R. Gautier S, et al. Among authors: bordet r. Stroke. 2003 Dec;34(12):2975-9. doi: 10.1161/01.STR.0000101914.62066.7B. Epub 2003 Nov 13. Stroke. 2003. PMID: 14615621

6

The neuroprotective effect of the antioxidant flavonoid derivate di-tert-butylhydroxyphenyl is parallel to the preventive effect on post-ischemic Kir2.x impairment but not to post-ischemic endothelial dysfunction.

Pétrault O, Bastide M, Cotelle N, Gelé P, Gautier S, Laprais M, Vamecq J, Duriez P, Bordet R. Pétrault O, et al. Among authors: bordet r. Naunyn Schmiedebergs Arch Pharmacol. 2004 Nov;370(5):395-403. doi: 10.1007/s00210-004-0966-x. Epub 2004 Oct 19. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 15502971

7

Vigilance states in a parkinsonian model, the MPTP mouse.

Monaca C, Laloux C, Jacquesson JM, Gelé P, Maréchal X, Bordet R, Destée A, Derambure P. Monaca C, et al. Among authors: bordet r. Eur J Neurosci. 2004 Nov;20(9):2474-8. doi: 10.1111/j.1460-9568.2004.03694.x. Eur J Neurosci. 2004. PMID: 15525288

8

Pharmacological neutropenia prevents endothelial dysfunction but not smooth muscle functions impairment induced by middle cerebral artery occlusion.

Pétrault O, Ouk T, Gautier S, Laprais M, Gelé P, Bastide M, Bordet R. Pétrault O, et al. Among authors: bordet r. Br J Pharmacol. 2005 Apr;144(8):1051-8. doi: 10.1038/sj.bjp.0706124. Br J Pharmacol. 2005. PMID: 15700030 Free PMC article.

9

The effects of serotoninergic, noradrenergic, cholinergic and dopaminergic drugs on vigilance states in MPTP-treated mice.

Laloux C, Derambure P, Jacquesson JM, Bordet R, Destée A, Monaca C. Laloux C, et al. Among authors: bordet r. Brain Res. 2007 Aug 3;1161:79-87. doi: 10.1016/j.brainres.2007.05.039. Epub 2007 Jun 2. Brain Res. 2007. PMID: 17586479

10

MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations.

Laloux C, Derambure P, Kreisler A, Houdayer E, Bruezière S, Bordet R, Destée A, Monaca C. Laloux C, et al. Among authors: bordet r. Exp Brain Res. 2008 Apr;186(4):635-42. doi: 10.1007/s00221-008-1268-1. Epub 2008 Jan 26. Exp Brain Res. 2008. PMID: 18224307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

420 results

Search Page